- Home
- IMNM vs FULTP Comparison
IMNM vs FULTP Comparison
Compare IMNM & FULTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- FULTP
- Stock Information
- Founded
- IMNM 2006
- FULTP N/A
- Country
- IMNM United States
- FULTP United States
- Employees
- IMNM N/A
- FULTP 3400
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- FULTP Major Banks
- Sector
- IMNM Health Care
- FULTP Finance
- Exchange
- IMNM Nasdaq
- FULTP Nasdaq
- Market Cap
- IMNM 747.7M
- FULTP N/A
- IPO Year
- IMNM 2020
- FULTP N/A
- Fundamental
- Price
- IMNM $12.45
- FULTP $19.09
- Analyst Decision
- IMNM Strong Buy
- FULTP
- Analyst Count
- IMNM 4
- FULTP 0
- Target Price
- IMNM $28.75
- FULTP N/A
- AVG Volume (30 Days)
- IMNM 801.6K
- FULTP N/A
- Earning Date
- IMNM 11-07-2024
- FULTP N/A
- Dividend Yield
- IMNM N/A
- FULTP N/A
- EPS Growth
- IMNM N/A
- FULTP N/A
- EPS
- IMNM N/A
- FULTP N/A
- Revenue
- IMNM $10,784,000.00
- FULTP N/A
- Revenue This Year
- IMNM N/A
- FULTP N/A
- Revenue Next Year
- IMNM N/A
- FULTP N/A
- P/E Ratio
- IMNM N/A
- FULTP N/A
- Revenue Growth
- IMNM 62.73
- FULTP N/A
- 52 Week Low
- IMNM $6.93
- FULTP N/A
- 52 Week High
- IMNM $30.96
- FULTP N/A
- Technical
- Relative Strength Index (RSI)
- IMNM 34.11
- FULTP 46.69
- Support Level
- IMNM $12.90
- FULTP $19.04
- Resistance Level
- IMNM $13.91
- FULTP $20.28
- Average True Range (ATR)
- IMNM 0.86
- FULTP 0.34
- MACD
- IMNM -0.25
- FULTP -0.08
- Stochastic Oscillator
- IMNM 4.87
- FULTP 13.77
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About FULTP Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Fulton Financial is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey, and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.